- Home
- OLP vs ARCT Comparison
OLP vs ARCT Comparison
Compare OLP & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OLP
- ARCT
- Stock Information
- Founded
- OLP 1982
- ARCT 2013
- Country
- OLP United States
- ARCT United States
- Employees
- OLP N/A
- ARCT N/A
- Industry
- OLP Real Estate Investment Trusts
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- OLP Real Estate
- ARCT Health Care
- Exchange
- OLP Nasdaq
- ARCT Nasdaq
- Market Cap
- OLP 584.2M
- ARCT 602.7M
- IPO Year
- OLP N/A
- ARCT N/A
- Fundamental
- Price
- OLP $30.10
- ARCT $17.50
- Analyst Decision
- OLP Strong Buy
- ARCT Strong Buy
- Analyst Count
- OLP 1
- ARCT 7
- Target Price
- OLP $28.00
- ARCT $65.00
- AVG Volume (30 Days)
- OLP 50.1K
- ARCT 489.1K
- Earning Date
- OLP 11-05-2024
- ARCT 11-07-2024
- Dividend Yield
- OLP 6.09%
- ARCT N/A
- EPS Growth
- OLP 51.11
- ARCT N/A
- EPS
- OLP 1.63
- ARCT N/A
- Revenue
- OLP $89,142,000.00
- ARCT $160,399,000.00
- Revenue This Year
- OLP N/A
- ARCT $13.02
- Revenue Next Year
- OLP $4.71
- ARCT $5.58
- P/E Ratio
- OLP $18.13
- ARCT N/A
- Revenue Growth
- OLP N/A
- ARCT N/A
- 52 Week Low
- OLP $19.25
- ARCT $14.93
- 52 Week High
- OLP $29.79
- ARCT $45.00
- Technical
- Relative Strength Index (RSI)
- OLP 68.79
- ARCT 42.89
- Support Level
- OLP $28.20
- ARCT $16.83
- Resistance Level
- OLP $28.89
- ARCT $18.31
- Average True Range (ATR)
- OLP 0.62
- ARCT 1.43
- MACD
- OLP 0.12
- ARCT -0.00
- Stochastic Oscillator
- OLP 100.00
- ARCT 31.06
About OLP One Liberty Properties Inc.
One Liberty Properties Inc is a self-administered and self-managed real estate investment trust. It acquires, owns, and manages a geographically diversified portfolio of industrial, retail, restaurant, health and fitness, and theater properties. OLP owns hundred and ten properties, including three properties owned by consolidated joint ventures and two properties owned by unconsolidated joint ventures. The hundred and ten properties are located in thirty one states. The group generates the majority of its revenue in the form of rental income.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.